Wang, G., Zhang, C., Tang, J., Ma, Z., Su, D., Zhang, Y. (2025). Cadonilimab in combination with ivonescimab and chemotherapy as first-line (1L) therapy in patients with advanced gastric (G) or gastroesophageal junction adenocarcinoma (GEJA).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16037